세계의 가정용 난임 치료 호르몬 패치 시장 보고서(2025년)
At-Home Fertility Hormone Patch Global Market Report 2025
상품코드 : 1877523
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,586,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,520,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,454,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 가정용 난임 치료 호르몬 패치 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 5억 1,000만 달러에서 2025년에는 5억 9,000만 달러에 달하고, CAGR 15.8%로 성장할 전망입니다. 이 성장은 불임증과 출산 연령의 지연에 대한 인식이 높아지고, 재택 진단 및 모니터링 기기의 보급 확대, 불임 치료 클리닉의 수용 능력 제약과 긴 대기 시간, 소비자용 원격 의료 서비스의 성장, 펨테크 및 여성 건강 스타트업에 대한 투자 증가 등이 요인으로 생각됩니다.

가정용 난임 치료 호르몬 패치 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년까지 10억 5,000만 달러에 달하고, CAGR은 15.4%가 될 전망입니다. 예측기간 동안의 성장요인으로는 세계 유통망과 소비자를 위한 직접 판매채널의 확대, 규제면에서의 유리한 경로와 상환정책, 생식 건강에 대한 의식향상, 재택 진단의 수용확대, 비침습적 난임 모니터링 수요 증가 등이 있습니다. 예측 기간의 주요 추세로는 웨어러블 호르몬 모니터링 혁신, 불임 상담을 위한 원격 의료 통합, 분석을 통한 개별화된 불임 추세 통찰력, 저렴한 가격에 중점을 둔 제품 개발, 호르몬 패치 기술의 발전 등이 있습니다.

불임증 증가 추세는 가정용 난임 치료 호르몬 패치 시장의 성장을 이끌 것으로 예측됩니다. 불임증이란, 피임을 하지 않고 정기적으로 성교를 실시해도 12개월 이상 임신에 이르지 않는 상태, 혹은 임신의 성립이나 임신 기간의 유지가 곤란한 상태를 말합니다. 유병률은 출산 연령의 지연으로 증가하고 있습니다. 보다 많은 개인이 가족 계획을 생식능력의 최고점을 넘은 시기로 연기하는 경향이 있으며, 연령에 따른 난자의 질, 난소 예비능, 정자 파라미터의 저하에 의해 임신 성공률이 저하하기 때문입니다. 불임증이 증가함에 따라 가정용 생식 호르몬 검사 솔루션에 대한 수요가 증가하고 있습니다. 이러한 패치는 생식 호르몬의 편리한 비침습적 모니터링을 가능하게 하며, 빈번한 통원 없이 배란 추적, 임신 가능 기간 식별, 정보를 기반으로 생식 건강에 대한 의사 결정을 지원합니다. 예를 들어, 2023년 4월에 세계보건기구(WHO)가 발표한 보고서에 따르면 세계 성인의 약 17.5%, 즉 6명 중 1명이 불임에 직면하여 접근 가능한 고품질의 불임 치료의 긴급성이 부각되었습니다. 이러한 불임증 증가 경향이 시장 성장을 견인하고 있는 것입니다.

여성의 건강 증진을 위한 노력에 대한 투자 확대는 가정용 난임 치료 호르몬 패치 시장의 성장을 가속할 것으로 예측됩니다. 여성의 건강 증진책에는 신체적, 정신적, 생식 건강의 향상을 목적으로 한 프로그램, 정책, 캠페인이 포함됩니다. 역사적으로 여성의 건강 문제가 경시되고, 단편적인 서비스와 불충분한 치료 결과로 이어진 의료 격차가 인식되는 가운데 투자는 증가하는 경향이 있습니다. 여성의 건강에 대한 자금 제공은 조사 촉진, 접근 개선, 생식 의료 격차 해소를 통해 가정용 난임 치료 호르몬 패치 등의 혁신을 지원하고 여성이 집에서 안전하게 불임 치료를 모니터링 및 관리할 수 있도록 지원합니다. 예를 들어, 2025년 3월에는 영국 보건 사회부가 개념 실증으로 여성 건강 허브를 설립하기 위해 2023-2024년도부터 2024-2025년도까지 3,200만 달러(약 2,500만 파운드)를 배분했습니다. 이처럼 여성 건강 이니셔티브에 대한 투자 확대는 시장 성장을 이끌고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

An at-home fertility hormone patch is a wearable device designed to monitor fertility-related hormone levels through the skin. It noninvasively collects biological data and transmits it to a connected platform for analysis. The technology enables convenient tracking of hormonal changes and identification of fertility patterns at home, providing valuable insights into reproductive health and assisting in predicting fertile windows for improved family planning or fertility management.

The primary product types of at-home fertility hormone patches are single-use patches and reusable patches. A single-use patch is a disposable, sterile medical device intended for one-time, single-patient use, offering simple, hygienic, and maintenance-free hormone tracking at home. These patches monitor hormones such as estrogen, progesterone, luteinizing hormone, follicle-stimulating hormone, and others. They are distributed through multiple channels, including online pharmacies, retail pharmacies, supermarkets or hypermarkets, and more. The patches are used for applications such as female and male fertility testing and are utilized by end-users including home care, clinics, hospitals, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The at-home fertility hormone patch market research report is one of a series of new reports from The Business Research Company that provides at-home fertility hormone patch market statistics, including at-home fertility hormone patch industry global market size, regional shares, competitors with the at-home fertility hormone patch market share, at-home fertility hormone patch market segments, market trends, and opportunities, and any further data you may need to thrive in the at-home fertility hormone patch industry. This at-home fertility hormone patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The at-home fertility hormone patch market size has grown rapidly in recent years. It will grow from $0.51 billion in 2024 to $0.59 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth during the historic period can be attributed to rising awareness of infertility and delayed childbearing, the increasing adoption of at-home diagnostic and monitoring devices, capacity constraints and long wait times at fertility clinics, growth in direct-to-consumer telemedicine services, and increased investment in femtech and women's health startups.

The at-home fertility hormone patch market size is expected to see rapid growth in the next few years. It will grow to $1.05 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth during the forecast period can be attributed to the expansion of global distribution and direct-to-consumer channels, favorable regulatory pathways and reimbursement policies, increasing awareness of reproductive health, growing acceptance of home-based diagnostics, and rising demand for non-invasive fertility monitoring. Key trends in the forecast period include innovations in wearable hormone monitoring, telehealth integration for fertility counseling, personalized fertility insights through analytics, affordability-focused product development, and advancements in hormone patch technology.

The increasing prevalence of infertility is expected to drive the growth of the at-home fertility hormone patch market. Infertility is defined as the inability to achieve pregnancy after 12 months of regular unprotected intercourse, or difficulties in conceiving or carrying a pregnancy to term. Its prevalence is rising due to delayed childbearing, as more individuals postpone family planning to later reproductive years, when age-related declines in egg quality, ovarian reserve, and sperm parameters reduce conception success rates. The growing burden of infertility boosts demand for at-home fertility hormone testing solutions, as these patches allow convenient, non-invasive monitoring of reproductive hormones, helping individuals track ovulation, identify fertile windows, and make informed reproductive health decisions without frequent clinic visits. For example, in April 2023, the World Health Organization reported that approximately 17.5% of adults globally, or about 1 in 6 people, face infertility, highlighting the urgent need for accessible, high-quality fertility care. The rising prevalence of infertility is therefore driving market growth.

Increasing investment in women's health initiatives is expected to propel the at-home fertility hormone patch market. Women's health initiatives include programs, policies, and campaigns aimed at improving physical, mental, and reproductive health. Investment is increasing due to recognition of historical healthcare disparities, where women's health concerns have often been overlooked, resulting in fragmented services and poor outcomes. Funding in women's health supports innovations such as at-home fertility hormone patches by promoting research, improving accessibility, and addressing gaps in reproductive healthcare, empowering women to monitor and manage fertility safely at home. For instance, in March 2025, the UK Department of Health and Social Care allocated $32 million (approximately £25 million) between financial years 2023-2024 and 2024-2025 to establish women's health hubs as a proof of concept. Growing investment in women's health initiatives is thus driving market growth.

Major companies in the at-home fertility hormone patch market are developing next-generation solutions, including DNA-based wearable patches for real-time, non-invasive hormone tracking. DNA-based wearable patches use DNA-derived sensors to detect hormone levels in interstitial fluid, allowing users to monitor hormonal fluctuations continuously without invasive blood tests, supporting fertility tracking and overall hormonal health. For example, in February 2025, Level Zero Health Inc., a UK biotechnology company, raised $6.9 million in an oversubscribed pre-seed funding round to develop the world's first continuous hormone monitoring patch. The DNA-based wearable patch measures hormones such as cortisol, progesterone, estrogen, and testosterone in interstitial fluid, providing real-time insights for fertility tracking, hormonal health management, and remote clinical monitoring. This arm-worn, non-invasive device reduces the need for clinic visits and invasive procedures. The company initially targets B2B clinical applications, including fertility clinics and endocrine treatment centers, with plans to expand into consumer-focused wellness markets.

Major players in the at-home fertility hormone patch market are Amneal Pharmaceuticals LLC, LetsGetChecked Limited, Kindbody Inc., Natural Cycles AB, Jolly Healthcare Pvt. Ltd., TMRW Life Sciences Inc., Easy-Healthcare-Corp, Tempdrop Inc., YO Home Test Inc., Hormona AB, FertilityIQ Inc., Inito Inc., myLAB Box Inc., SteadySense Inc., Persperity Health Inc., Muun Health Inc., Bea Fertility Inc., Level Zero Health Inc., Maman Biomedical Inc., Cue Health.

North America was the largest region in the at-home fertility hormone patch market in 2024. The regions covered in at-home fertility hormone patch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the at-home fertility hormone patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The at-home fertility hormone patch market consists of sales of multi-hormone tracking patches, temperature and hormone combination patches, estrogen delivery patches, progesterone delivery patches, follicle-stimulating hormone (FSH) micro-needle patches, combination hormone therapy patches, smart fertility tracking patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

At-Home Fertility Hormone Patch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on at-home fertility hormone patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for at-home fertility hormone patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The at-home fertility hormone patch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. At-Home Fertility Hormone Patch Market Characteristics

3. At-Home Fertility Hormone Patch Market Trends And Strategies

4. At-Home Fertility Hormone Patch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global At-Home Fertility Hormone Patch Growth Analysis And Strategic Analysis Framework

6. At-Home Fertility Hormone Patch Market Segmentation

7. At-Home Fertility Hormone Patch Market Regional And Country Analysis

8. Asia-Pacific At-Home Fertility Hormone Patch Market

9. China At-Home Fertility Hormone Patch Market

10. India At-Home Fertility Hormone Patch Market

11. Japan At-Home Fertility Hormone Patch Market

12. Australia At-Home Fertility Hormone Patch Market

13. Indonesia At-Home Fertility Hormone Patch Market

14. South Korea At-Home Fertility Hormone Patch Market

15. Western Europe At-Home Fertility Hormone Patch Market

16. UK At-Home Fertility Hormone Patch Market

17. Germany At-Home Fertility Hormone Patch Market

18. France At-Home Fertility Hormone Patch Market

19. Italy At-Home Fertility Hormone Patch Market

20. Spain At-Home Fertility Hormone Patch Market

21. Eastern Europe At-Home Fertility Hormone Patch Market

22. Russia At-Home Fertility Hormone Patch Market

23. North America At-Home Fertility Hormone Patch Market

24. USA At-Home Fertility Hormone Patch Market

25. Canada At-Home Fertility Hormone Patch Market

26. South America At-Home Fertility Hormone Patch Market

27. Brazil At-Home Fertility Hormone Patch Market

28. Middle East At-Home Fertility Hormone Patch Market

29. Africa At-Home Fertility Hormone Patch Market

30. At-Home Fertility Hormone Patch Market Competitive Landscape And Company Profiles

31. At-Home Fertility Hormone Patch Market Other Major And Innovative Companies

32. Global At-Home Fertility Hormone Patch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The At-Home Fertility Hormone Patch Market

34. Recent Developments In The At-Home Fertility Hormone Patch Market

35. At-Home Fertility Hormone Patch Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기